NCT02594514

Brief Summary

Severe obesity (SO), defined as BMI≥95th percentile, has increased worldwide among adolescents. American studies estimated that 1.3-2.8% of 12-19-year-old individuals have a BMI \>40 kg/m2 or a BMI \>35 kg/m2 with at least one serious co-morbidity. The immediate and long-term risks associated with SO in adolescents include cardiovascular and metabolic diseases, obstructive sleep apnoea and nonalcoholic fatty liver disease. However, the results of sleeve gastrectomy in adolescents are still uncertain. Objective and hypotheses: Investigators aimed to assess the long-term safety, efficacy, and cardiovascular risk changes of laparoscopic sleeve gastrectomy in adolescents with SO. Method: Longitudinal retrospective study of 22 adolescents with SO who underwent laparoscopic sleeve gastrectomy. Clinical and metabolic variables immediately before surgery and after 6, 12, 18 and 24 months were assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2015

Completed
25 days until next milestone

First Posted

Study publicly available on registry

November 3, 2015

Completed
Last Updated

November 3, 2015

Status Verified

October 1, 2015

Enrollment Period

7.9 years

First QC Date

October 9, 2015

Last Update Submit

October 30, 2015

Conditions

Keywords

cardiovascular riskmetabolic profile

Outcome Measures

Primary Outcomes (2)

  • Percent of loss of excess weight following laparoscopic sleeve gastrectomy in severely obese adolescents

    weight

    up to 24 months

  • percent of reduction in body mass index following laparoscopic sleeve gastrectomy in severely obese adolescents

    weight and stature

    up to 24 months

Secondary Outcomes (8)

  • Changes in insulin resistance following laparoscopic sleeve gastrectomy in severely obese adolescents

    up to 24 months

  • Changes in total cholesterol and and fractions following laparoscopic sleeve gastrectomy in severely obese adolescents

    up to 24 months

  • Changes in glucose and and fractions following laparoscopic sleeve gastrectomy in severely obese adolescents

    up to 24 months

  • Changes in transaminases following laparoscopic sleeve gastrectomy in severely obese adolescents

    up to 24 months

  • Changes in uric acid following laparoscopic sleeve gastrectomy in severely obese adolescents

    up to 24 months

  • +3 more secondary outcomes

Eligibility Criteria

Age14 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Severe obese adolescents who underwent laparoscopic sleeve gastrectomy

You may qualify if:

  • ages of 14 and 19
  • submitted to LSG between 2007 and 2014.
  • attended the child obesity clinic of the pediatric endocrinology department of the Instituto da Criança da Universidade de São Paulo (Children's Institute of University of São Paulo).
  • received clinical and pharmacological treatment for at least 6 months before surgery and were followed by a multidisciplinary team including a pediatric endocrinologist, a nutritionist, a psychologist and a physical educator.
  • BMI \> 40 kg/m2 or BMI \> 35 kg/m2 with comorbidities and failed to achieve significant weight loss (10% of initial weight at 6 months) through clinical treatment.
  • Both the patients and their guardians were informed about the risks and benefits of surgery and provided informed consent.

You may not qualify if:

  • it was a retrospective study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HCFUMSP

São Paulo, São Paulo, 0543-010, Brazil

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

October 9, 2015

First Posted

November 3, 2015

Study Start

January 1, 2007

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

November 3, 2015

Record last verified: 2015-10

Locations